학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 73건 | 목록 1~20
Academic Journal
Zugasti I; Hematology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. izugasti@clinic.cat.; Josep Carreras Leukemia Research Institute, Barcelona, Spain. izugasti@clinic.cat.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain. izugasti@clinic.cat.; Espinosa-Aroca L; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Fidyt K; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Mulens-Arias V; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Diaz-Beya M; Hematology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Juan M; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain.; Department of Immunology, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Departments of Biomedical Sciences and Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Immunotherapy Joint Platform of Hospital Sant Joan de Deu and Hospital Clínic de Barcelona, Barcelona, Spain.; Urbano-Ispizua Á; Hematology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain.; Departments of Biomedical Sciences and Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Esteve J; Hematology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Departments of Biomedical Sciences and Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Velasco-Hernandez T; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain.; Departments of Biomedical Sciences and Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Menéndez P; Josep Carreras Leukemia Research Institute, Barcelona, Spain. pmenendez@carrerasresearch.org.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain. pmenendez@carrerasresearch.org.; Departments of Biomedical Sciences and Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. pmenendez@carrerasresearch.org.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. pmenendez@carrerasresearch.org.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. pmenendez@carrerasresearch.org.; Pediatric Cancer Centre Barcelona-Institut de Recerca Sant Joan de Deu (PCCB-SJD), Barcelona, Spain. pmenendez@carrerasresearch.org.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE
Academic Journal
Tirado N; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Fidyt K; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Mansilla MJ; OneChain Immunotherapeutics S.L, Barcelona, Spain.; Garcia-Perez A; OneChain Immunotherapeutics S.L, Barcelona, Spain.; Martínez-Moreno A; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Vinyoles M; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Alcain J; Centro de Biología Molecular Severo Ochoa CSIC-UAM, Madrid, Spain.; García-Peydró M; Centro de Biología Molecular Severo Ochoa CSIC-UAM, Madrid, Spain.; Roca-Ho H; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Fernandez-Fuentes N; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Guerrero-Murillo M; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Falgàs A; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Velasco-Hernandez T; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Bueno C; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Panelli P; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Mulens-Arias V; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Apostolov A; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Engel P; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; González EA; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.; Vick B; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Munich, German Research Center for Environmental Health (HMGU), Munich, Germany.; Jeremias I; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Munich, German Research Center for Environmental Health (HMGU), Munich, Germany.; Department of Pediatrics, Dr. von Hauner Children's Hospital, LMU University Hospital, LMU Munich, Munich, Germany.; Caye-Eude A; Department of Genetics, University Hospital Robert Debré; INSERM Institut de Recherche Saint Louis, Paris, France.; Baruchel A; Department of Genetics, University Hospital Robert Debré; INSERM Institut de Recherche Saint Louis, Paris, France.; Cavé H; Department of Genetics, University Hospital Robert Debré; INSERM Institut de Recherche Saint Louis, Paris, France.; Genescà E; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Ribera J; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.; Department of Hematology, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona, Spain.; Díaz-Beyá M; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Martínez-Sánchez MV; Immunology Service, Clinical University Hospital Virgen de la Arrixaca, Instituto Murciano de Investigación Sanitaria (IMIB), University of Murcia, Murcia, Spain.; Fuster JL; Sección de Oncohematología Pediátrica, Hospital Clínico Universitario Virgen de la Arrixaca; Instituto Murciano de Investigación Sanitaria (IMIB), University of Murcia, Murcia, Spain.; Escudero López A; Department of Genetics, Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain.; Minguillón J; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; CIBERER-ISCIII, IdiPAZ-CNIO Translational Research Unit in Pediatric Hemato-Oncology, La Paz University Hospital Research Institute; Spanish National Cancer Center, Madrid, Spain.; Advanced Therapies Mixed Unit, CIEMAT/IIS-FJD, Madrid, Spain.; Pérez-Martínez A; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; CIBERER-ISCIII, IdiPAZ-CNIO Translational Research Unit in Pediatric Hemato-Oncology, La Paz University Hospital Research Institute; Spanish National Cancer Center, Madrid, Spain.; Advanced Therapies Mixed Unit, CIEMAT/IIS-FJD, Madrid, Spain.; Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain.; Ramírez-Orellana M; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain.; Hospital Infantil Universitario Niño Jesús, Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.; Torrebadell M; Institut de Recerca Pediàtrica Sant Joan de Déu; Department of Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.; Díaz VM; OneChain Immunotherapeutics S.L, Barcelona, Spain.; Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain.; Toribio ML; Centro de Biología Molecular Severo Ochoa CSIC-UAM, Madrid, Spain. mtoribio@cbm.csic.es.; Sánchez-Martínez D; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain. dsanchez@iisaragon.es.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain. dsanchez@iisaragon.es.; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain. dsanchez@iisaragon.es.; Aragon Foundation for Research & Development (ARAID), Zaragoza, Spain. dsanchez@iisaragon.es.; Menéndez P; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain. pmenendez@carrerasresearch.org.; Red Española de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain. pmenendez@carrerasresearch.org.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. pmenendez@carrerasresearch.org.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain. pmenendez@carrerasresearch.org.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. pmenendez@carrerasresearch.org.; Institut de Recerca Hospital Sant Joan de Déu-Pediatric Cancer Center Barcelona (SJD-PCCB), Barcelona, Spain. pmenendez@carrerasresearch.org.
Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE
Academic Journal
Bobrowicz M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Kusowska A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Krawczyk M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Doctoral School of Translational Medicine, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Zhylko A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Forcados C; Translational Research Unit, Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Slusarczyk A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Department of General, Oncological and Functional Urology, Medical University of Warsaw, Warsaw, Poland.; Barankiewicz J; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Faculty of Medicine, Lazarski University, Warsaw, Poland.; Domagala J; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Kubacz M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Šmída M; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Dostalova L; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Marhelava K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Pepek M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Baranowska I; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Szumera-Cieckiewicz A; Department of Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Biobank, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Inderberg EM; Translational Research Unit, Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Wälchli S; Translational Research Unit, Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Granica M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Graczyk-Jarzynka A; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Majchrzak M; Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.; Poreba M; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.; Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland.; Gehlert CL; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany.; Peipp M; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany.; Firczuk M; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Prochorec-Sobieszek M; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany.; Winiarska M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Academic Journal
Domagala J; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Grzywa TM; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; The Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Baranowska I; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Justyniarska M; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Tannir R; The Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; College of Arts and Sciences, University of Pennsylvania, Philadelphia, Pennsylvania.; Graczyk-Jarzynka A; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Kusowska A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Lecka M; Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.; Poreba M; Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.; Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland.; Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Marhelava K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Pilch Z; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Picard LK; Department for Immunology, Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund, Dortmund, Germany.; Wegierski T; International Institute of Molecular and Cell Biology, Warsaw, Poland.; Jastrzebski K; International Institute of Molecular and Cell Biology, Warsaw, Poland.; Krawczyk M; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Doctoral School of Translational Medicine, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Klopotowska M; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Granica M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Urlaub D; Department for Immunology, Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund, Dortmund, Germany.; Hajduk S; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Neeser A; The Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Moros S; The Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Kozlowski P; Central Laboratory, University Clinical Centre of the Medical University of Warsaw, Warsaw, Poland.; Bobrowicz M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Miaczynska M; International Institute of Molecular and Cell Biology, Warsaw, Poland.; Ma L; The Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.; Watzl C; Department for Immunology, Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund, Dortmund, Germany.; Winiarska M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Academic Journal
Marhelava K; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Pepek M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Krawczyk M; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School of Translational Medicine, Mossakowski Medical Research Institute, Polish Academy of Sciences, Centre of Postgraduate Medical Education, Warsaw, Poland.; Forcados C; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Malinowska A; Mass Spectrometry Laboratory, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.; Swiderska B; Mass Spectrometry Laboratory, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.; Fernandez-Fuentes N; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Czerwik N; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Baranowska I; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Krzywdzinska A; Laboratory of Immunophenotyping, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Sedek L; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Slota L; Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice, Zabrze, Poland.; Perkowski B; Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice, Zabrze, Poland.; Villatoro A; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Leray T; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Lech-Maranda E; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Menendez P; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red-Oncología, Instituto de Salud Carlos III, Madrid, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Institut de Recerca Hospital Sant Joan de Déu-Pediatric Cancer Center Barcelona (SJD-PCCB), Barcelona, Spain.; Inderberg EM; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Wälchli S; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Winiarska M; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland. mwiniarska@imdik.pan.pl.; Department of Immunology, Medical University of Warsaw, Warsaw, Poland. mwiniarska@imdik.pan.pl.; Firczuk M; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland. mfirczuk@imdik.pan.pl.; Department of Immunology, Medical University of Warsaw, Warsaw, Poland. mfirczuk@imdik.pan.pl.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Krawczyk M; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School of Translational Medicine, Mossakowski Medical Research Institute, Polish Academy of Sciences, Centre of Postgraduate Medical Education, Warsaw, Poland.; Fernandez-Fuentes N; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Winiarski T; Warsaw University of Technology, Institute of Control and Computation Engineering, Warsaw, Poland.; Pepek M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Graczyk-Jarzynka A; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Davis J; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Bousquets-Muñoz P; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Puente XS; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Menendez P; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Red Española de Terapias Avanzadas (TERAV) - Instituto de Salud Carlos III (ISCII).; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Institut de Recerca Hospital Sant Joan de Déu-Pediatric Cancer Center Barcelona (SJD-PCCB), Barcelona, Spain.; Benard E; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Wälchli S; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Thomas-Tikhonenko A; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Winiarska M; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Academic Journal
Domka K; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences, Warsaw, Poland; Department of Immunology, Medical University of Warsaw, Warsaw.; Dąbkowska A; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences, Warsaw, Poland; Department of Immunology, Medical University of Warsaw, Warsaw.; Janowska M; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences, Warsaw.; Urbańska Z; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland; Department of Genetic Predisposition to Cancer, Medical University of Lodz, Lodz.; Pastorczak A; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland; Department of Genetic Predisposition to Cancer, Medical University of Lodz, Lodz.; Winiarska M; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences, Warsaw, Poland; Department of Immunology, Medical University of Warsaw, Warsaw.; Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw.; Lachota M; Laboratory of Cellular and Genetic Therapies, Medical University of Warsaw, Warsaw, Poland; Department of Ophthalmology, Children's Memorial Health Institute, Warsaw.; Patkowska E; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw.; Sędek Ł; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia, Katowice.; Perkowski B; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia, Katowice.; Hunia J; Department of Immunology, Medical University of Warsaw, Warsaw.; Jakubowska J; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz.; Krzymieniewska B; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw.; Lech-Marańda E; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw.; Młynarski W; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz.; Szczepański T; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia, Katowice.; Firczuk M; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences, Warsaw, Poland; Department of Immunology, Medical University of Warsaw, Warsaw. mfirczuk@imdik.pan.pl.
Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Academic Journal
Goral A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Firczuk M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Sledz M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Simoncello F; Cellular Immunology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.; Siudakowska K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Pagano G; Tumor-Stroma Interactions, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Moussay E; Tumor-Stroma Interactions, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Paggetti J; Tumor-Stroma Interactions, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Nowakowska P; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Gobessi S; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.; Barankiewicz J; Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Salomon-Perzynski A; Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Benvenuti F; Cellular Immunology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.; Efremov DG; Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.; Juszczynski P; Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Lech-Maranda E; Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Muchowicz A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
Komorowski L; Department of Immunology Medical University of Warsaw Warsaw Poland.; Postgraduate School of Molecular Medicine Medical University of Warsaw Warsaw Poland.; Dabkowska A; Department of Immunology Medical University of Warsaw Warsaw Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences Warsaw Poland.; Madzio J; Department of Pediatrics, Oncology and Hematology Medical University of Lodz Lodz Poland.; Pastorczak A; Department of Pediatrics, Oncology and Hematology Medical University of Lodz Lodz Poland.; Szczygiel K; Department of Immunology Medical University of Warsaw Warsaw Poland.; Polpharma Biologics SA Gdańsk Poland.; Janowska M; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences Warsaw Poland.; Fidyt K; Department of Immunology Medical University of Warsaw Warsaw Poland.; Bielecki M; Department of Psychology SWPS University of Social Sciences and Humanities Warsaw Poland.; Hunia J; Department of Immunology Medical University of Warsaw Warsaw Poland.; Bajor M; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences Warsaw Poland.; Stoklosa T; Department of Tumor Biology and Genetics Medical University of Warsaw Warsaw Poland.; Winiarska M; Department of Immunology Medical University of Warsaw Warsaw Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences Warsaw Poland.; Patkowska E; Institute of Hematology and Transfusion Medicine Warsaw Poland.; Firczuk M; Department of Immunology Medical University of Warsaw Warsaw Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences Warsaw Poland.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Academic Journal
Wachowska M; Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Str., F Building, 02-097, Warsaw, Poland.; Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age Medical, University of Warsaw, Warsaw, Poland.; Stachura J; Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Str., F Building, 02-097, Warsaw, Poland.; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.; Tonecka K; Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Str., F Building, 02-097, Warsaw, Poland.; Fidyt K; Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Str., F Building, 02-097, Warsaw, Poland.; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.; Braniewska A; Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Str., F Building, 02-097, Warsaw, Poland.; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.; Sas Z; Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Str., F Building, 02-097, Warsaw, Poland.; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.; Kotula I; Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age Medical, University of Warsaw, Warsaw, Poland.; Rygiel TP; Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Str., F Building, 02-097, Warsaw, Poland.; Boon L; Bioceros BV, Utrecht, The Netherlands.; Golab J; Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Str., F Building, 02-097, Warsaw, Poland. jakub.golab@wum.edu.pl.; Centre for Preclinical Research and Technology, Medical University of Warsaw, Warsaw, Poland. jakub.golab@wum.edu.pl.; Muchowicz A; Department of Immunology, Medical University of Warsaw, Nielubowicza 5 Str., F Building, 02-097, Warsaw, Poland. angelika.muchowicz@wum.edu.pl.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Academic Journal
Fidyt K; Department of Immunology, Medical University of Warsaw, Poland.; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Poland.; Pastorczak A; Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland.; Goral A; Department of Immunology, Medical University of Warsaw, Poland.; Szczygiel K; Department of Immunology, Medical University of Warsaw, Poland.; Fendler W; Department of Biostatistics and Translational Medicine, Medical University of Lodz, Poland.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Muchowicz A; Department of Immunology, Medical University of Warsaw, Poland.; Bartlomiejczyk MA; Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland.; Madzio J; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Poland.; Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland.; Cyran J; Department of Immunology, Medical University of Warsaw, Poland.; Graczyk-Jarzynka A; Department of Immunology, Medical University of Warsaw, Poland.; Jansen E; Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Patkowska E; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Lech-Maranda E; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Centre of Postgraduate Medical Education, Warsaw, Poland.; Pal D; Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.; Blair H; Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.; Burdzinska A; Department of Immunology, Transplantology and Internal Diseases, Medical University of Warsaw, Poland.; Pedzisz P; Department of Orthopaedics and Traumatology, Medical University of Warsaw, Poland.; Glodkowska-Mrowka E; Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw, Poland.; Demkow U; Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw, Poland.; Gawle-Krawczyk K; Department of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Poland.; Matysiak M; Department of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Poland.; Winiarska M; Department of Immunology, Medical University of Warsaw, Poland.; Juszczynski P; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Mlynarski W; Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland.; Heidenreich O; Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.; Golab J; Department of Immunology, Medical University of Warsaw, Poland.; Centre for Preclinical Research and Technology, Medical University of Warsaw, Poland.; Firczuk M; Department of Immunology, Medical University of Warsaw, Poland.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Academic Journal
Casey NP; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Klee CH; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Fåne A; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Caulier B; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Center for Cancer Cell Reprogramming (CanCell), Institute for Clinical Medicine, University of Oslo, Oslo, Norway; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Graczyk-Jarzynka A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Krawczyk M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Josefsson SE; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Köksal H; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Dillard P; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Patkowska E; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Firczuk M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Smeland EB; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Winiarska M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Myklebust JH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Inderberg EM; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: elsmar@rr-research.no.; Wälchli S; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: sebastw@rr-research.no.
Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE
Academic Journal
Marhelava K; Department of Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland.; Krawczyk M; Department of Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland.; Doctoral School of Translational Medicine, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland.; Firczuk M; Department of Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland.; Fidyt K; Department of Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE
Academic Journal
Pastorczak A; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, 91-738 Lodz, Poland.; Domka K; Department of Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland.; Doctoral School, Medical University of Warsaw, 02-091 Warsaw, Poland.; Fidyt K; Department of Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland.; Postgraduate School of Molecular Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland.; Poprzeczko M; Department of Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland.; Firczuk M; Department of Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Pawlak A; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wroclaw, Poland.; Ziolo E; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wroclaw, Poland.; Fiedorowicz A; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wroclaw, Poland.; Fidyt K; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wroclaw, Poland.; Strzadala L; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wroclaw, Poland.; Kalas W; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114, Wroclaw, Poland. kalas@iitd.pan.wroc.pl.; Jan Dlugosz University in Czestochowa, Waszyngtona 4/8, 42-200, Czestochowa, Poland. kalas@iitd.pan.wroc.pl.
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Academic Journal
Komorowski L; Department of Immunology, Medical University of Warsaw, Nielubowicza 5 St, 02-097 Warsaw, Poland.; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Trojdena 2a St, 02-091 Warsaw, Poland.; Fidyt K; Department of Immunology, Medical University of Warsaw, Nielubowicza 5 St, 02-097 Warsaw, Poland.; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Trojdena 2a St, 02-091 Warsaw, Poland.; Patkowska E; Department of Hematology, Institute of Hematology and Transfusion Medicine, Indiry Gandhi 14, 02-776 Warsaw, Poland.; Firczuk M; Department of Immunology, Medical University of Warsaw, Nielubowicza 5 St, 02-097 Warsaw, Poland.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Fidyt, K.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어